The role of IGFBP-5 in mediating the anti-proliferation effect of tetrandrine in human colon cancer cells
Open Access
- 17 December 2014
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 46 (3), 1205-1213
- https://doi.org/10.3892/ijo.2014.2800
Abstract
Colon cancer is one of the most common malignancies, causes considerable morbidity and mortality. The current treatment for colon cancer is more modest than had been hoped. There is an urgent clinical need to explore new agents or adjuvants for colon cancer treatment. Natural products and their derivates act as one of the major source for anticancer agent. In the present study, we investigated the anti-proliferation and chemoprevention effects of tetrandrine (Tet) on colon cancer cells to uncover the possible molecular basis of this effect. We found that Tet can inhibit proliferation and induce apoptosis in LoVo cells. With dimethylhydrazine (DMH) and dextran sodium sulfate (DSS) induced colon cancer model, we found that Tet can prevent or inhibit DMH plus DSS induced aberrant crypt foci (ACF) and colon cancer formation, as well as suppress tumor growth in the xenograft colon cancer model. Tet can downregulate the expression of IGFBP-5 in LoVo cells. Exogenous expression of IGFBP-5 can attenuate the anti-cancer activity of Tet, while IGFBP-5 knockdown potentiates this effect of Tet on LoVo cells. Tet can inhibit Wnt/β-catenin signaling transduction, which can be partly reversed by exogenous expression of IGFBP-5, but is enhanced by IGFBP-5 knockdown. Our results demonstrated that the anticancer activity of Tet in colon cancer cells may be mediated partly by downregulating the expression of IGFBP-5, thus inactivating Wnt/β-catenin signaling transduction.Keywords
This publication has 47 references indexed in Scilit:
- Current Approaches and Challenges for Monitoring Treatment Response in Colon and Rectal CancerJournal of Cancer, 2014
- Tetrandrine, a Compound Common in Chinese Traditional Medicine, Preferentially Kills Breast Cancer Tumor Initiating Cells (TICs) In VitroCancers, 2011
- Tetrandrine Inhibits Wnt/β-Catenin Signaling and Suppresses Tumor Growth of Human Colorectal CancerMolecular Pharmacology, 2010
- Colorectal cancerThe Lancet, 2010
- Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and TrialsCell, 2007
- The evolving role of natural products in drug discoveryNature Reviews Drug Discovery, 2005
- Natural products in cancer chemotherapy: past, present and futureNature Reviews Cancer, 2002
- Anti-Inflammatory Effects of the Partially Purified Extract of RadixStephaniae tetrandrae: Comparative Studies of Its Active Principles Tetrandrine and Fangchinoline on Human Polymorphonuclear Leukocyte FunctionsMolecular Pharmacology, 2001
- Natural products in anticancer therapyCurrent Opinion in Pharmacology, 2001
- Anti-inflammatory and immunosuppressive properties of the bis-benzylisoquinolines: In vitro comparisons of tetrandrine and berbamineInternational Journal of Immunopharmacology, 1989